Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia
✍ Scribed by Ismene L. Petrakis; Stephanie O’Malley; Bruce Rounsaville; James Poling; Colette McHugh-Strong; John H. Krystal
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 181 KB
- Volume
- 172
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background Depressive symptoms are common in older patients with schizophrenia; yet, few studies have examined the usefulness of antidepressants in this population. ## Objective We conducted a 10‐week single‐blind trial of citalopram (20–40 mg/day) vs no citalopram augmentation in
## Abstract We conducted structured interviews of patients with Parkinson's disease (PD) and other parkinsonian disorders and their caregivers after augmentation of vocal folds with collagen injections. A total of 12 patients (mean age, 73.7 ± 8.6 years) completed the questionnaire after an average